221
|
|
|
Methylcrotonyl-CoA carboxylase subunit 2 |
MCCB, MCCCbeta |
|
222
|
|
|
Mitochondrial coiled-coil domain 1 |
- |
|
223
|
|
|
Methylmalonyl-CoA epimerase |
GLOD2, MCE, MMCE |
|
224
|
|
|
MCF.2 cell line derived transforming sequence like |
ARHGEF14, DBS, OST |
Appendicitis, Cardiovascular disease, Central nervous system cancer, Coronary artery disease, Dementia, Glioblastoma, Glioma, Oligodendroglioma, Osteoarthritis, Urinary bladder cancer, Venous thromboembolism |
225
|
|
|
MCF.2 cell line derived transforming sequence-like 2 |
ARHGEF22 |
|
226
|
|
|
Multiple coagulation factor deficiency 2, ER cargo receptor complex subunit |
F5F8D, F5F8D2, LMAN1IP, SDNSF |
|
227
|
|
|
Melanin concentrating hormone receptor 1 |
GPR24, MCH-1R, MCH1R, SLC-1, SLC1 |
|
228
|
|
|
Melanin concentrating hormone receptor 2 |
GPR145, GPRv17, MCH-2R, MCH-R2, MCH2, MCH2R, MCHR-2, SLT |
|
229
|
|
|
Multiciliate differentiation and DNA synthesis associated cell cycle protein |
CILD42, IDAS, MCI, MCIN |
|
230
|
|
|
MCL1 apoptosis regulator, BCL2 family member |
BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT |
Barrett esophagus, Biliary tract cancer, Breast cancer, Cancer, Cervical cancer, Colorectal cancer, Coronary artery disease, Endometrial cancer, Esophageal cancer, Estrogen-receptor negative breast cancer, Gastric cancer, Hepatocellular carcinoma, Hypertension, Leishmaniasis, Lung cancer, Lung neoplasms, Multiple myeloma, Non-hodgkins lymphoma, Ovarian cancer, Ovarian serous carcinoma, Pancreatic cancer, Prostate cancer, Sarcoidosis, Sarcoma, Schizophrenia, Myopia, Squamous cell carcinomaView all (12 more) |